1.
Studies on Expression of Human Tissue Factor Pathway Inhibitor-2 in Pichia Pastoris;
重组人组织因子途径抑制物-2在毕赤酵母中表达的研究
2.
Study on Large-scale Fermentation and Purification of Recombinant Human Tissue Factor Pathway Inhibitor 2;
重组人组织因子途径抑制物2的大规模发酵及纯化的研究
3.
Molecular Cloning, Expression and Characterization, Pharmacodynamics Studies of Recombinant Human Tissue Factor Pathway Inhibitor and Its Mutants;
重组人组织因子途径抑制物及其突变体的基因克隆、表达与性质和药效学的初步研究
4.
Construction of recombinant pET28a-leptin based on human adipose tissues
基于人脂肪组织获取基因构建pET28a-leptin(瘦素)重组子
5.
The Effects of Connective Tissue Growth Factor on Survival of the Random Skin Flap in Rats;
重组人结缔组织生长因子对大鼠背部超长皮瓣成活的影响
6.
Optimization of Expression Conditions for Purification of Recombinant Tissue Factor Pathway Inhibitors
组织因子途径抑制因子重组蛋白表达和纯化方法的优化
7.
Construction of eukaryotic expression plasmid for human TF full-length,TF truncated and characterization of their biological function
全长及细胞内磷酸化位点缺失的人组织因子真核表达重组质粒的构建及其生物学功能
8.
The effect of recombinant human connective tissure growth factor on the expression of α5β1 integrin and fibronectin in renal tubular epithenial cells
重组人结缔组织生长因子对肾小管上皮细胞表达α5β1整合素及纤连蛋白的影响
9.
Expression of Tumor Necrosis Factor Alpha in Subcutaneous and Omental Adipose Tissues of Overweight Individuals;
肿瘤坏死因子α在超重者脂肪组织中的表达
10.
Role of connective tissue growth factor in the airway remodeling in asthma
结缔组织生长因子在哮喘气道重塑中的作用
11.
Expression and Significance of CDT1 in Human Normal Hepatic Tissue and HCC Tissue;
复制许可因子CDT1在人正常肝脏组织和肝癌组织中的表达与意义
12.
Humen Granulocyte Colony Stimulating Factor
[重组]人粒细胞集落刺激因子
13.
Human Granulocyte Macrophage Colony Stimulating Factor
[重组]人粒细胞巨噬细胞集落刺激因子
14.
Study on Expression and Purification of Recombinant Human Coagulation Factor Ⅶ in Mammalian Cell Line;
重组人凝血因子Ⅶ的表达与纯化研究
15.
Prominent member of a group
（一组织中的）重要人物
16.
Prokaryotic Vector Construction and Expression of Murine Tissue Factor
小鼠组织因子原核质粒的构建和重组蛋白的表达
17.
Generation and Application of Active Recombinant Mouse Tissue Factor and Its Function-blocking Monoclonal Antibody
重组活性小鼠组织因子及其阻断性单抗的制备与应用
18.
Transfer of Organizational Capital:New Interpretation for the Motivation of Assets Restructuring;
组织资本的转移:资产重组动因新解